Ann: Successful Completion of Final Pre-Clinical PK Study, page-2

Wonderful news!

From the announcement.... "the completion of this pharmacokinetics study is the final study required to finalise the Company’s ethics submission."

Emphasis, "FINAL."

Further in the announcement.... "Completion of the PK study now completes all studies required for ethics submission. The only outstanding item of work is the completion of the analysis of pathology samples from the GLP toxicology studies. This work was delayed due to the extensive lockdown in Shanghai impacting the Clinical Research Organisation’s access to laboratories. The pathology analysis has now commenced and is expected to be completed in the coming weeks."

And once that has been received ethics approval can be submitted.

The company remains on track.